Availability of clinical laboratories for the assessment of cardiovascular risk in Catalonia
Rubiés-Prat, J.; Pedro-Botet, J.
Medicina Clinica 110(9): 358-359
1998
ISSN/ISBN: 0025-7753 PMID: 9567274 Document Number: 486548
Document emailed within 1 workday
Related Documents
Whittaker, R.; Bramley, D.; Wells, S.; Stewart, A.; Selak, V.; Furness, S.; Rafter, N.; Roseman, P.; Jackson, R. 2006: Will a web-based cardiovascular disease (CVD) risk assessment programme increase the assessment of CVD risk factors for Maori? New Zealand Medical Journal 119(1238): U2077St-Pierre, J.; Vohl, M-Claude.; Després, J-Pierre.; Gaudet, D.; Poirier, P. 2005: Genetic aspects of diabetes and its cardiovascular complications: contribution of genetics to risk assessment and clinical management Canadian Journal of Cardiology 21(2): 199-209
Wang, L-nan.; Zhang, R.; Shen, Z-yu.; Chen, W-xiang.; Li, J-ming. 2008: External quality assessment on detection of hepatitis C virus RNA in clinical laboratories of China Chinese Medical Journal 121(11): 1032-1036
Rosales-Alexander, J.L.; Salvatierra, J.; Llorca, J.; Magro-Checa, C.; González-Gay, M.A.; Cantero-Hinojosa, J.; Raya-Álvarez, E. 2014: Cardiovascular risk assessment in rheumatoid arthritis: impact of the EULAR recommendations on a national calibrated score risk index Clinical and Experimental Rheumatology 32(2): 237-242
Edwards-Jackson, N.; Kerr, S.; Tieu, H.; Ananworanich, J.; Hammer, S.; Ruxrungtham, K.; Phanuphak, P.; Avihingsanon, A. 2011: Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected Thais HIV Medicine 12(8): 510-515
Pardell, H.; Tresserras, R.; Taberner, J.L.; Via, J.M.; Salleras, L. 1993: Cardiovascular and hypertension targets in the health plan for Catalonia (Spain) Journal of Human Hypertension 7(6): 543-545
Lobos-Bejarano, Jé.M.; Royo-Bordonada, M.Angel.; Brotons-Cuixart, C. 2005: Use of tables for cardiovascular risk assessment in elderly people Medicina Clinica 125(11): 438; Author Reply 438-9
Anand, S.S.; Yusuf, S. 1997: Risk factors for cardiovascular disease in Canadians of South Asian and European origin: a pilot study of the Study of Heart Assessment and Risk in Ethnic Groups (SHARE) Clinical and Investigative Medicine 20(4): 204-210
Chevalier, L.; Douard, H.; Laporte, T.; Hajjar, M.; Baudot, C.; Genson, F.; Labanere, C.; Merle, F.; Gencel, L.; Vincent, M.P. 2005: Survey of cardiovascular risk assessment and the behaviour of a sporting population Archives des Maladies du Coeur et des Vaisseaux 98(2): 109-114
Stehouwer, C.D.A.; Gansevoort, R.T. 2009: Measurement of protein loss in the urine. a useful addition in cardiovascular disease risk assessment Nederlands Tijdschrift Voor Geneeskunde 153(17): 796
Thomas, S. 2009: Measurement of protein loss in the urine. not a useful addition in cardiovascular disease risk assessment Nederlands Tijdschrift Voor Geneeskunde 153(17): 797
Anand, S.S.; Yusuf, S.; Vuksan, V.; Devanesen, S.; Teo, K.K.; Montague, P.A.; Kelemen, L.; Yi, C.; Lonn, E.; Gerstein, H.; Hegele, R.A. 2000: Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE) Indian Heart Journal 52(7 Suppl): S35-S43
Kleber, M.E.; Winkler, K.; Wolfert, R.L.; Delgado, G. de Moissl; Grammer, T.B.; Dietz, S.; Winkelmann, B.R.; Boehm, B.O.; Winfried März 2011: Lipoprotein Associated Phospholipase A2 Concentration Predicts Total and Cardiovascular Mortality Independently of Established Risk Factors (The Ludwigshafen Risk and Cardiovascular Health Study) Clinical Laboratory 57(9-10): 659-667
Baena Díez, Jé.Miguel.; Del Val García, Jé.Luis.; Alemany Vilches, L.; Martínez Martínez, Jé.Luis.; Tomàs Pelegrina, J.; González Tejón, Ián.; Raidó Quintana, E.María.; Rovira España, Mónica. 2005: Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in Barcelona Revista espanola de salud publica 79: 365-378
Snežana Jovičić; Ignjatovi, S.ć; Dajak, M.; Kangrga, R.; Majki, N.ć-Singh 2009: Association of Lipid and Inflammatory Markers with C-Reactive Protein in Cardiovascular Risk Assessment for Primary Prevention Clinical Laboratory 55(11-12): 411-419
Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Hernández-Bronchud, M. 1996: Hereditary predisposition to breast cancer: assessment of genetic risk and recommendations for the clinical follow-up of high-risk cases Medicina Clinica 107(10): 383-387
T, D.; Mv, K. 2020: Assessment of Cardiovascular Risk with Atherogenic Markers in Subclinical Hypothyroidism: with Special Reference to Carotid Intima Media Thickness (CIMT) and High Sensitive CRP (hsCRP) Journal of the Association of Physicians of India 68(1): 45
Barros, Z.M.; de Alencar Ximenes, R.A.; Miranda-Filho, D.óc.B.; de Albuquerque, M.d.F.át.P.M.ão.; Melo, H.ís.R.L.; Carvalho, E.H.; Gelenske, T.; Diniz, G.; Bandeira, F. 2010: Comparison between the Framingham and prospective cardiovascular of Münster scores for risk assessment of coronary heart disease in human immunodeficiency virus-positive patients in Pernambuco, Brazil Metabolic Syndrome and Related Disorders 8(6): 489-497
Clarke, D.B.; Kelly, J.; Wilson, L.A. 2002: Assessment of performance of laboratories in determining acrylamide in crispbread Journal - Association of Official Analytical Chemists 85(6): 1370-1373